Clinical Trials

Showing trials with last updates posted in 2024.

NCT05215574 | ACTIVE_NOT_RECRUITING | PHASE1
130 participants

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2024-10-10
Start Date:
2022-03-31
Completion:
2025-07-31
Conditions
  • Pancreatic Cancer
  • Breast Cancer
  • Gastric Cancer
  • Non-small Cell Lung Cancer
  • Cervical Cancer
  • Endocervical Cancer
  • Squamous Cell Carcinoma of Head and Neck
  • Bladder Urothelial Cancer
  • Colorectal Carcinoma
  • Esophageal Cancer
  • Ovarian Cancer
  • Renal Cell Carcinoma
  • Prostate Cancer
  • Melanoma
  • Mesothelioma
  • Cholangiocarcinoma
Interventions
  • DRUG
No Results Yet
NCT05028257 | COMPLETED | PHASE3
117 participants

Allergy and COVID-19 Vaccines

Study Type:
INTERVENTIONAL
Last Updated:
2024-10-10
Start Date:
2021-09-15
Completion:
2023-05-22
Conditions
  • Anaphylactic Reaction
  • Vaccine Reaction
Interventions
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page